3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
249
Carcinoma, Non-Small-Cell Lung
224
Prostatic Neoplasms
114
Neoplasms
105
Multiple Myeloma
90
Neoplasm Metastasis
74
Colorectal Neoplasms
73
Parkinson Disease 4, Autosomal Dominant Lewy Body
69
Lung Neoplasms
64
Ovarian Neoplasms
61
Leukemia, Myeloid, Acute
50
Melanoma
47
Carcinoma, Hepatocellular
47
Carcinoma, Renal Cell
45
Leukemia, Lymphocytic, Chronic, B-Cell
44
Triple Negative Breast Neoplasms
42
Urinary Bladder Neoplasms
41
Stomach Neoplasms
41
Squamous Cell Carcinoma of Head and Neck
41
Recurrence
40
Brain Neoplasms
39
Myasthenia Gravis
37
Small Cell Lung Carcinoma
34
Nasopharyngeal Carcinoma
34
Lymphoma, Follicular
34
Head and Neck Neoplasms
34
Rectal Neoplasms
31
Pancreatic Neoplasms
31
Lymphoma, Large B-Cell, Diffuse
30
Endometrial Neoplasms
29
Interventions
pertuzumab
1
Trastuzumab
1
Surgical Procedures, Operative
1
Radiotherapy
1
Injections, Subcutaneous
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Patient Preference
×
1 year
×
Clear all
NCT05415215
2026-02-10
ProHer
Hoffmann-La Roche
Phase 3
Completed
346 enrolled
20 charts